Treatment of schizophrenia with INVEGA

Abstract

The article comments the results of a 6-month prospective, randomized, controlled study with a direct comparison of paliperidone ER versus oral olanzapine in patients with schizophrenia.

Keywords

• paloperidone
• olanzapine
• weight
• lipids
• diabetes mellitus
• insulin resistance
• metabolic syndrome